Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity.
Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more.
Since its inception, Yissum has registered 10,000+ patents covering 3,000+ inventions; licensed 950+ technologies and produced 150+ spin-off companies.
MISSION & CORE VALUES
Yissum serves as a bridge between cutting-edge academic research and a global community of entrepreneurs, investors, and industry organizations. Yissum’s expertise in innovation, collaboration, and operational excellence supports the commercialization of Hebrew University’s transformational and translational discoveries.
Through our activities, we facilitate:
- Long-term industry-university collaborations through sponsored research, licensing options and master collaborations.
- Start-up creation and support
- Enterprise directed research
- Leverage of government research funds
- Education and training within and outside the university